Startup to Develop Periodontitis Vaccine
2020-03-11
An Australian startup will use a $14 million investment to develop a vaccine for periodontal disease, which affects a third of all adults around the
CSL Limited
An Australian startup will use a $14 million investment to develop a vaccine for periodontal disease, which affects a third of all adults around the